Homayouni Vida, Khanahmad Hossein, Ganjalikhani-Hakemi Mazdak, Behdani Mahdi, Ghasemi Pouria, Rezaei Abbas
Immunology Department, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Genetic Department, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Iran J Biotechnol. 2017 Sep 27;15(3):166-171. doi: 10.15171/ijb.1427. eCollection 2017.
T cell Immunoglobulin, Mucin (TIM)-3, is a type I transmembrane glycoprotein belonging to TIM family. This receptor expresses on T helper type 1 (Th1) cells that binds to galectin-9 (Gal9); inducing an inhibitory signal. As a result, apoptosis of Th1 cells occurs and cytotoxicity of CD8 T cells becomes evident in vitro. Therefore, this immunomodulatory molecule may be used as a novel target for clinical purposes. The production of camel polyclonal antibodies against TIM-3-expressing cell line was the purpose of this study. In this study, we aimed to use HEK 293 cells expressing human TIM-3 to obtain camel polyclonal antibody against TIM-3 by immunization. A pre-synthesized human TIM-3cDNA was inserted into pcDNA3.1 plasmid and the new construct was transfected in HEK cell. TIM-3 expression was confirmed by qRT-PCR and flow cytometry. A camel (6 months old) was immunized with the lysate prepared from rTIM-3 expressing HEK cells 4 times. The anti-TIM-3 antibody level was evaluated using ELISA method. TIM-3 was successfully cloned in HEK cells with 88% success rate. High level of anti-TIM-3 antibody was detected in the serum of the camel immunized with the recombinant cell lysate, after final injection. Our rhTIM-3 cell display system can be useful for future diagnostic or therapeutic approaches.
T细胞免疫球蛋白黏蛋白(TIM)-3是一种属于TIM家族的I型跨膜糖蛋白。该受体在1型辅助性T(Th1)细胞上表达,可与半乳糖凝集素-9(Gal9)结合,诱导抑制性信号。结果,Th1细胞发生凋亡,CD8 T细胞的细胞毒性在体外变得明显。因此,这种免疫调节分子可作为临床应用的新靶点。本研究的目的是制备针对表达TIM-3的细胞系的骆驼多克隆抗体。在本研究中,我们旨在利用表达人TIM-3的HEK 293细胞通过免疫获得抗TIM-3的骆驼多克隆抗体。将预先合成的人TIM-3 cDNA插入pcDNA3.1质粒,并将新构建体转染到HEK细胞中。通过qRT-PCR和流式细胞术确认TIM-3的表达。用表达rTIM-3的HEK细胞制备的裂解物对一头6个月大的骆驼进行4次免疫。采用ELISA法评估抗TIM-3抗体水平。TIM-3在HEK细胞中成功克隆,成功率为88%。在最后一次注射后,在用重组细胞裂解物免疫的骆驼血清中检测到高水平的抗TIM-3抗体。我们的rhTIM-3细胞展示系统可用于未来的诊断或治疗方法。